Navigation Links
Novel Method of Adult Stem Cell Growth may Help to Treat Cornea Disorders

Ophthalmologists at the University Clinic of the University of Navarra have confirmed the efficacy of a self-designed, novel method of adult stem cell growth for its capacity to grow cornea stem cells in animal studies.

Ana Fernandez Hortelano, ophthalmologist at the hospital, applied the growth technique for the treatment of diseases of cornea in 70 rabbits for the purpose of regaining the damaged epithelium, and thus restoring transparency to the cornea.

The experiments proved the therapeutic efficiency in using corneal stem cells in patients with pathologies of the cornea, such as caustications or ocular herpes, by using stem cells from a healthy contralateral eye.

Dr Fernandez Hortelanos procedure involved obtaining corneal stem cells by means of a biopsy of cells from a healthy eye of the rabbit. Since the sample of cells is as small as 3 by 4 mm, it does not expose the contrateral eye to danger.

The implantation of the adult stem cells so obtained in the damaged eye lead to the recovery of the corneal epithelium, and thereby, the transparency of the cornea.

Experiments on rabbits with induced limbic insufficiency showed that 60 per cent of the animals had recovered the corneal epithelium after the adult stem cells transplant.

The corneal epithelium is the layer that is damaged with limbic insufficiency, a problem that results in opacity of the cornea in the long term.

According to researchers, the importance of this growth method lies in the fact that it enables the characterisation of the cells obtained, that is, determination of the quantity and viability of the units to be used.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: